Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Kate Priestman bought 23,564 shares of the stock in a transaction that occurred on Tuesday, April 30th. The shares were purchased at an average price of GBX 106 ($1.33) per share, with a total value of £24,977.84 ($31,375.25).
Oxford Nanopore Technologies Price Performance
ONT stock opened at GBX 101.20 ($1.27) on Thursday. The company has a debt-to-equity ratio of 6.47, a current ratio of 5.01 and a quick ratio of 6.01. The firm has a market capitalization of £870.28 million, a P/E ratio of -674.67 and a beta of 0.59. The business's 50-day moving average is GBX 121.31 and its two-hundred day moving average is GBX 162.04. Oxford Nanopore Technologies plc has a 1 year low of GBX 91.24 ($1.15) and a 1 year high of GBX 279 ($3.50).
Wall Street Analyst Weigh In
A number of brokerages recently commented on ONT. Berenberg Bank restated a "buy" rating and set a GBX 350 ($4.40) target price on shares of Oxford Nanopore Technologies in a report on Wednesday, April 17th. Citigroup reaffirmed a "buy" rating and issued a GBX 210 ($2.64) price target on shares of Oxford Nanopore Technologies in a research report on Friday, April 12th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of GBX 303.75 ($3.82).
View Our Latest Stock Analysis on Oxford Nanopore Technologies
About Oxford Nanopore Technologies
(
Get Free Report)
Elon’s New Device is About to Shock the World
From InvestorPlace | Ad
Using this device you see above…
Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in…
“The next step in human evolution.”
Click here to see the details because there’s a lot of money at stake.
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
